Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry

2017 ◽  
Vol 36 (4) ◽  
pp. 753-761 ◽  
Author(s):  
Sara Monti ◽  
Catherine Klersy ◽  
Roberto Gorla ◽  
Piercarlo Sarzi-Puttini ◽  
Fabiola Atzeni ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Biologic Therapy ◽  
Real Life ◽  
Second Line ◽  
Life Data ◽  
Factors Influencing ◽  
Real Life Data

scholarly journals Real-life data of Atezolizumab in urothelial carcinoma, second-line metastatic disease

2020 ◽  
Vol 21 ◽  
pp. S217
Author(s):  
L.F. Sánchez-Cousido ◽  
Á. Rodríguez Sánchez ◽  
A. Lanz Lozano ◽  
M. López Flores ◽  
A. López González ◽  
...  
Keyword(s):  
Urothelial Carcinoma ◽  
Metastatic Disease ◽  
Real Life ◽  
Second Line ◽  
Life Data ◽  
Real Life Data

scholarly journals Effects of Anti-TNF Alpha Drugs on Disability in Patients with Rheumatoid Arthritis: Long-Term Real-Life Data from the Lorhen Registry

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Matteo Filippini ◽  
Chiara Bazzani ◽  
Fabiola Atzeni ◽  
Piercarlo Sarzi Puttini ◽  
Antonio Marchesoni ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Marked Improvement ◽  
Real Life ◽  
Tnf Alpha ◽  
First Year ◽  
Life Data ◽  
Highly Active ◽  
Real Life Data ◽  
History Of

This study involving 1033 patients with RA confirms the effectiveness of etanercept, adalimumab, and infliximab in reducing RA-related disability even in patients with a history of highly active and longstanding RA. Moreover, we found that the improvement in disability was biphasic, with a marked improvement during the first year of anti-TNF therapy, followed by slower but significant recovery over the subsequent four years.

scholarly journals Twelve-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: Real-Life Data From a Local Registry

2016 ◽  
Vol 68 (4) ◽  
pp. 432-439 ◽  
Author(s):  
Ennio Giulio Favalli ◽  
Francesca Pregnolato ◽  
Martina Biggioggero ◽  
Andrea Becciolini ◽  
Alessandra Emiliana Penatti ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Retention Rate ◽  
Real Life ◽  
Tumor Necrosis Factor Inhibitors ◽  
First Line ◽  
Life Data ◽  
Real Life Data ◽  
Necrosis Factor

scholarly journals Real-life data of Cabazitaxel-Prednisone second-line scheme in metastatic castration-resistant prostate cancer

2020 ◽  
Vol 21 ◽  
pp. S151
Author(s):  
L.F. Sánchez-Cousido ◽  
Á. Rodríguez Sánchez ◽  
M. López Flores ◽  
A. López González ◽  
B. Castañón González ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Real Life ◽  
Second Line ◽  
Castration Resistant Prostate Cancer ◽  
Life Data ◽  
Castration Resistant ◽  
Real Life Data
Sign in / Sign up

Export Citation Format

Share Document